The CardioMessenger Smart provides fully automatic transmission of vital information from a patient’s cardiac implant to their physician over a GSM cellular network. To use the device, the patient simply needs to connect it to a power source; it then automatically transmits the data to the BIOTRONIK Home Monitoring Service Center, using wireless, coded, telemetry. Consistent and reliable data transmission occurs both daily or when triggered by an event, and a call back message for patients enables physicians to get in contact with their patients whenever necessary.

 

BIOTRONIK Home Monitoring is intended to replace device interrogation during in-office follow-up visits, and to provide early detection of arrhythmias. It is available in over 55 countries, optimizing patient management around the world. Features offered include intelligent early detection, customizable fully programmable alerts with options to specify alert thresholds and ranges, and call-back alerts to notify the patient to contact the clinic. BIOTRONIK Home Monitoring and the CardioMessenger Smart are products of BIOTRONIK (Berlin, Germany).

 

“Recent years have seen a shift towards early detection and prevention. By helping healthcare providers better manage their patients, Home Monitoring improves the efficacy and safety of cardiac rhythm therapy,” said Wolf Ruhnke, vice president of BIOTRONIK. “Patient-centric advanced technologies like Home Monitoring allow implant patients to go about their lives with the peace of mind that comes from knowing they are taken care of, anywhere, anytime.” 

 

“Home Monitoring alerts me to relevant changes in patient or device status, ensuring that I always see the right patient at the right time,” said Volker Leonhardt, MD, director of telemedicine at Herzschrittmacher-Zentrum (HIZ; Berlin, Germany; www.stimulation.de). “I can keep track of each patient without subjecting him to needlessly intrusive in-person follow-ups and react quickly when necessary. This has clear clinical advantages for the patient, especially for heart failure patients.”